Indivior Pharmaceuticals, Inc. INDV Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermInvestments.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's equity method investments?
- Indivior Pharmaceuticals, Inc. (INDV) reported equity method investments of $27M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's equity method investments changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's equity method investments decreased by 0.0% year-over-year, from $27M to $27M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's equity method investments?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc. 's equity method investments has grown at a -17.4% compound annual growth rate (CAGR), from $41M to $28M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.